A 5iTech Company
Safe, Painless, Easy Way to Preserve and Improve Health of the Eye  OCULATEKTM 9000 has been introduced in Europe and has achieved broad recognition  and success in extensive trials in cooperation with the world renowned Hemholtz  Institute. More than 500,000 patients have already been successfully treated with  OCULATEKTM devices. In addition to general consumer applications for presbyopia and myopia, OCULATEKTM    therapy has been shown to have substantial, measurable therapeutic effect reducing  eye stress and fatigue among aircraft pilots and heavy computer users. Use of  OCULATEKTM devices resulted in preservation of visual acuity and a substantial increase in a pilots’ flight time availability. 
Presbyopia is the gradual loss of the eyes'  ability to focus on nearby objects. It's a  natural, often annoying part of aging.  Presbyopia usually becomes noticeable in  your early to mid-40s and continues to  worsen until around age 65. Patients become aware of presbyopia  when they start holding books and  newspapers at arm's length to be able to  read them.  -- Mayo Cliinic Staff 
OCULATEKTM Transcleral Light Therapay System  Designed to improve vision for presyopes and myopes by  strengthening the ciliary muscle of the eye and restoring the  accomodative reserve of the eye 
Has been shown to: Reduces or eliminates dependence on reader glasses or bifocals Preserves vision Facilitates post surgical recovery 
© All Rights Reserved. OculatekTM 2015.
Not available in US. Not yet FDA Approved IN U.S. FOR INVESTIGATIONAL USE ONLY
Contact:  Leon Polott +1 330-554-6856 lapolott@5itech.com
Jim Ohneck, CEO +1 440 785-2298  johneck@oculatek.com
1768 E. 25th Street, Cleveland, Ohio 44114